Rankings
▼
Calendar
LXRX Q1 2025 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+11.7% YoY
Gross Profit
$1M
97.6% margin
Operating Income
-$26M
-2034.8% margin
Net Income
-$25M
-2004.4% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
-95.2%
Cash Flow
Operating Cash Flow
-$44M
Free Cash Flow
-$44M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$298M
Total Liabilities
$175M
Stockholders' Equity
$123M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$1M
+11.7%
Gross Profit
$1M
$955,000
+29.0%
Operating Income
-$26M
-$45M
+43.4%
Net Income
-$25M
-$48M
+47.7%
Revenue Segments
License
$45
100%
← FY 2025
All Quarters
Q2 2025 →